Urgent request for pretomanid label expansion to align with WHO guidelines and improve treatment accessibility and efficacy by L. Kuksa, C. Andrejak, B. Haecker, G. Bothamley, A. Calcagno, D.M. Cirillo, R. Duarte, R. Fatima, G. Ferlazzo, L. Guglielmetti, G. Günther, C. Hewison, C.R. Horsburgh, T. Jäger, Y. Kalancha, R. Otto-Knapp, K. Kranzer, T. Lillebaek, G. Marks, K. Middelkoop, I. Motta, V. Rabinova, P. Sommerfeld, P. Tattevin, C. Lange

Get full text

Effectiveness of a bedaquiline, linezolid, clofazimine ‘core’ for multidrug-resistant TB by C. Zeng, M.A. Hernán, L. Trevisi, S. Sauer, C.D. Mitnick, C. Hewison, M. Bastard, P. Khan, K.J. Seung, M.L. Rich, S. Law, M. Kikvidze, O. Kirakosyan, A. Miankou, P. Thit, S. Mamsa, A. Janmohamed, N. Melikyan, S. Ahmed, D. Vargas, A.B. Binegdie, K. Temirova, L. Oyewusi, K. Philippe, S.C. Vilbrun, U. Khan, H. Huerga, M.F. Franke, on behalf of the endTB Observational Study Team

Get full text